OpGen OpGen Q2 Revenues Fall 32 Percent The decline was driven by the dissolution of the firm's FISH business and the completion of an R&D project at subsidiary Ares Genetics. OpGen Q1 Revenues Rise 34 Percent on Combination With Curetis OpGen said it is awaiting a clearance decision for its Unyvero pneumonia cartridge in China, where it is currently under review and pending approval. OpGen Fourth Quarter Revenues Increase 64 Percent The company's full-year revenues were $4.2 million, up 20 percent from the year-ago quarter. OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval The company's cartridge for pneumonia for the Unyvero system is under review and pending approval by Chinese regulators. OpGen Enters $25M Direct Offering Agreement A single healthcare-focused investor will purchase 2.78 million shares of common stock, 5.55 million prefunded warrants, and an additional 4.17 million shares of common stock. Jan 13, 2021 OpGen Preliminary Q4 Revenue Climbs 63 Percent Nov 24, 2020 OpGen Inks $10M Private Placement Agreement Nov 11, 2020 OpGen Posts 70 Percent Increase in Q3 Revenues Amid Shuffling of Portfolio Oct 15, 2020 OpGen Posts 54 Percent Increase in Preliminary Q3 Revenues, Consolidates Product Portfolio Oct 14, 2020 OpGen Provides Additional Info to FDA on Antimicrobial Resistance Gene Panel Sep 30, 2020 Curetis Receives €350K German Government Grant to Develop Carbapenem Resistance Test Aug 20, 2020 OpGen Nabs CE-IVD Mark for SARS-CoV-2 Kit Aug 12, 2020 OpGen Q2 Revenues Climb 20 Percent Jul 15, 2020 OpGen Preliminary Q2 Revenues Increase 20 Percent Jul 13, 2020 OpGen to Distribute Menarini Silicon Cellsearch Platform in North America for COVID-19 Applications Jul 9, 2020 Curetis Gains Access to Additional €5 Million Debt Financing for COVID-19 R&D Jun 3, 2020 OpGen Expands Partnership With New York State Department of Health to Detect AMR Infections May 7, 2020 OpGen Q1 Revenues Drop 38 Percent Apr 21, 2020 Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients Apr 14, 2020 OpGen Q1 Preliminary Revenues Down 38 Percent Mar 24, 2020 OpGen Fourth Quarter Revenues Increase 8 Percent Feb 20, 2020 Curetis Preliminary 2019 Revenues Up 64 Percent Feb 12, 2020 OpGen Preliminary 2019 Revenues up 19 Percent Jan 30, 2020 Ares Genetics Collaborates With BGI on Coronavirus Testing in Europe Dec 20, 2019 FDA Clears Curetis Lower Respiratory Tract Infections Panel Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.